Nu-Med Plus, Inc. (NUMD)

Nu-Med Plus Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0	0.01	0.07	0.01	0.19
Cash & Short-Term Investments	0	0.01	0.07	0.01	0.19
Cash Growth	-65.13%	-90.70%	526.94%	-93.81%	2562.89%
Prepaid Expenses	0.01	0.01	0.01	-	0.35
Total Current Assets	0.01	0.01	0.08	0.01	0.54
Property, Plant & Equipment	-	-	-	0.01	0.02
Total Assets	0.01	0.01	0.08	0.02	0.56
Accounts Payable	0.11	0.05	0.04	0.05	0.05
Accrued Expenses	0.01	0.01	0	0.09	0.03
Short-Term Debt	0.1	0.1	0.1	-	-
Current Portion of Leases	-	-	-	0.01	0.01
Total Current Liabilities	0.22	0.16	0.14	0.15	0.08
Long-Term Debt	-	-	-	-	0.01
Total Liabilities	0.22	0.16	0.14	0.15	0.09
Common Stock	0.08	0.08	0.08	0.08	0.05
Additional Paid-In Capital	9.59	9.59	9.56	9.36	8.43
Retained Earnings	-9.89	-9.82	-9.7	-9.57	-8.74
Comprehensive Income & Other	-	-	-	-	0.72
Shareholders' Equity	-0.22	-0.15	-0.06	-0.13	0.47
Total Liabilities & Equity	0.01	0.01	0.08	0.02	0.56
Total Debt	0.1	0.1	0.1	0.01	0.02
Net Cash (Debt)	-0.1	-0.09	-0.03	0	0.17
Net Cash Growth	-	-	-	-97.98%	-
Net Cash Per Share	-0.00	-0.00	-0.00	0.00	0.00
Filing Date Shares Outstanding	83.55	83.55	81.35	79.35	79.35
Total Common Shares Outstanding	83.55	83.55	81.35	79.35	51.03
Working Capital	-0.22	-0.15	-0.06	-0.14	0.46
Book Value Per Share	-0.00	-0.00	-0.00	-0.00	0.01
Tangible Book Value	-0.22	-0.15	-0.06	-0.13	0.47
Tangible Book Value Per Share	-0.00	-0.00	-0.00	-0.00	0.01
Machinery	-	-	-	0.09	0.09

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.